Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,377,699
in 4 filings, $108K under 10b5-1 plans

Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-30 BERBERIAN LANCE EVP, CIO & CTO Grant or award +4,509 24,677
2023-03-30 BERBERIAN LANCE EVP, CIO & CTO Shares withheld for taxes −1,799 $224.70 $404K 22,878
2023-03-30 Schroeder Mark S EVP, President-Diagnostics Lab Grant or award 10b5-1 +6,763 13,450.4
2023-03-30 Schroeder Mark S EVP, President-Diagnostics Lab Shares withheld for taxes 10b5-1 −2,866 $224.70 $644K 10,584.4
2023-03-30 Seltz Judith C EVP, CHRO Grant or award +3,381 5,345.95
2023-03-30 Seltz Judith C EVP, CHRO Shares withheld for taxes −1,164 $224.70 $262K 4,181.95
2023-03-30 Summy Amy B. EVP, Chief Marketing Officer Grant or award +3,234 4,903
2023-03-30 Summy Amy B. EVP, Chief Marketing Officer Shares withheld for taxes −1,269 $224.70 $285K 3,634
2023-03-30 van der Vaart Sandra D EVP, Chief Legal Officer Grant or award +3,609 9,161.76
2023-03-30 van der Vaart Sandra D EVP, Chief Legal Officer Shares withheld for taxes −1,371 $224.70 $308K 7,790.76
2023-03-30 Wilkinson Peter J SVP, Chief Accounting Officer Grant or award +1,798 3,958.22
2023-03-30 Wilkinson Peter J SVP, Chief Accounting Officer Shares withheld for taxes −526 $224.70 $118K 3,432.22
2023-03-02 Summy Amy B. EVP, Chief Marketing Officer Exercise or conversion +1,340 2,043
2023-03-02 Summy Amy B. EVP, Chief Marketing Officer Shares withheld for taxes −374 $239.46 $90K 1,669
2023-03-02 Summy Amy B. EVP, Chief Marketing Officer Exercise or conversion · Restricted Stock Unit −1,340 1,180
2023-02-21 Kirchgraber Paul R CEO, Covance Drug Development Exercise or conversion +3,000 $182.51 $548K 17,069
2023-02-21 Kirchgraber Paul R CEO, Covance Drug Development Sale −8,000 $250.58 $2.0M 9,069
2023-02-21 Kirchgraber Paul R CEO, Covance Drug Development Exercise or conversion · Non-qualified Stock Options −3,000 4,300
2023-02-14 Schroeder Mark S EVP, President-Diagnostics Lab Sale −309 $247.63 $77K 6,687.4
2023-02-13 BELINGARD JEAN-LUC Director Shares withheld for taxes −75 $248.13 $19K 16,929

Page 38 of 41 · 816 trades